188 related articles for article (PubMed ID: 22204908)
21. Potent inhibitors of malarial aspartic proteases, the plasmepsins, by hydroformylation of substituted 7-azanorbornenes.
Aureggi V; Ehmke V; Wieland J; Schweizer WB; Bernet B; Bur D; Meyer S; Rottmann M; Freymond C; Brun R; Breit B; Diederich F
Chemistry; 2013 Jan; 19(1):155-64. PubMed ID: 23161835
[TBL] [Abstract][Full Text] [Related]
22. [Selective inhibitors of plasmepsin II from Plasmodium falciparum based on pepstatin].
Rumsh LD; Mikhaĭlova AG; Mikhura IV; Prudchenko IA; Chikin LD; Mikhaleva II; Kaliberda EN; Dergousova NI; Mel'nikov EE; Formanovskiĭ AA
Bioorg Khim; 2008; 34(6):739-46. PubMed ID: 19088746
[TBL] [Abstract][Full Text] [Related]
23. Design and discovery of plasmepsin II inhibitors using an automated workflow on large-scale grids.
Degliesposti G; Kasam V; Da Costa A; Kang HK; Kim N; Kim DW; Breton V; Kim D; Rastelli G
ChemMedChem; 2009 Jul; 4(7):1164-73. PubMed ID: 19437467
[TBL] [Abstract][Full Text] [Related]
24. Macrocyclic inhibitors of the malarial aspartic proteases plasmepsin I, II, and IV.
Ersmark K; Nervall M; Gutiérrez-de-Terán H; Hamelink E; Janka LK; Clemente JC; Dunn BM; Gogoll A; Samuelsson B; Qvist J; Hallberg A
Bioorg Med Chem; 2006 Apr; 14(7):2197-208. PubMed ID: 16307884
[TBL] [Abstract][Full Text] [Related]
25. Discovery of non-peptide inhibitors of Plasmepsin II by structure-based virtual screening.
Song Y; Jin H; Liu X; Zhu L; Huang J; Li H
Bioorg Med Chem Lett; 2013 Apr; 23(7):2078-82. PubMed ID: 23466235
[TBL] [Abstract][Full Text] [Related]
26. Identification of plasmepsin inhibitors as selective anti-malarial agents using ligand based drug design.
McKay PB; Peters MB; Carta G; Flood CT; Dempsey E; Bell A; Berry C; Lloyd DG; Fayne D
Bioorg Med Chem Lett; 2011 Jun; 21(11):3335-41. PubMed ID: 21531557
[TBL] [Abstract][Full Text] [Related]
27. Antiplasmodial activity of hydroxyethylamine analogs: Synthesis, biological activity and structure activity relationship of plasmepsin inhibitors.
Kumar Singh A; Rajendran V; Singh S; Kumar P; Kumar Y; Singh A; Miller W; Potemkin V; Poonam ; Grishina M; Gupta N; Kempaiah P; Durvasula R; Singh BK; Dunn BM; Rathi B
Bioorg Med Chem; 2018 Jul; 26(13):3837-3844. PubMed ID: 29983285
[TBL] [Abstract][Full Text] [Related]
28. Click Inspired Synthesis of Novel Cinchonidine Glycoconjugates as Promising Plasmepsin Inhibitors.
Mishra N; Agrahari AK; Bose P; Singh SK; Singh AS; Tiwari VK
Sci Rep; 2020 Feb; 10(1):3586. PubMed ID: 32108142
[TBL] [Abstract][Full Text] [Related]
29. Plasmepsin II inhibition and antiplasmodial activity of Primaquine-Statine 'double-drugs'.
Romeo S; Dell'Agli M; Parapini S; Rizzi L; Galli G; Mondani M; Sparatore A; Taramelli D; Bosisio E
Bioorg Med Chem Lett; 2004 Jun; 14(11):2931-4. PubMed ID: 15125962
[TBL] [Abstract][Full Text] [Related]
30. Exploring dual inhibitory role of febrifugine analogues against Plasmodium utilizing structure-based virtual screening and molecular dynamic simulation.
Pandey RK; Narula A; Naskar M; Srivastava S; Verma P; Malik R; Shah P; Prajapati VK
J Biomol Struct Dyn; 2017 Mar; 35(4):791-804. PubMed ID: 26984239
[TBL] [Abstract][Full Text] [Related]
31. Targeting the Plasmodium falciparum plasmepsin V by ligand-based virtual screening.
Meissner KA; Kronenberger T; Maltarollo VG; Trossini GHG; Wrenger C
Chem Biol Drug Des; 2019 Mar; 93(3):300-312. PubMed ID: 30320974
[TBL] [Abstract][Full Text] [Related]
32. Synthesis of malarial plasmepsin inhibitors and prediction of binding modes by molecular dynamics simulations.
Ersmark K; Nervall M; Hamelink E; Janka LK; Clemente JC; Dunn BM; Blackman MJ; Samuelsson B; Aqvist J; Hallberg A
J Med Chem; 2005 Sep; 48(19):6090-106. PubMed ID: 16162010
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and Evaluation of N-(3-Trifluoroacetyl-indol-7-yl) Acetamides for Potential In Vitro Antiplasmodial Properties.
Mphahlele MJ; Mmonwa MM; Choong YS
Molecules; 2017 Jul; 22(7):. PubMed ID: 28671598
[TBL] [Abstract][Full Text] [Related]
34. Additional interaction of allophenylnorstatine-containing tripeptidomimetics with malarial aspartic protease plasmepsin II.
Hidaka K; Kimura T; Tsuchiya Y; Kamiya M; Ruben AJ; Freire E; Hayashi Y; Kiso Y
Bioorg Med Chem Lett; 2007 Jun; 17(11):3048-52. PubMed ID: 17400453
[TBL] [Abstract][Full Text] [Related]
35. Identification and characterization of allophenylnorstatine-based inhibitors of plasmepsin II, an antimalarial target.
Nezami A; Luque I; Kimura T; Kiso Y; Freire E
Biochemistry; 2002 Feb; 41(7):2273-80. PubMed ID: 11841219
[TBL] [Abstract][Full Text] [Related]
36. alpha-Substituted norstatines as the transition-state mimic in inhibitors of multiple digestive vacuole malaria aspartic proteases.
Orrling KM; Marzahn MR; Gutiérrez-de-Terán H; Aqvist J; Dunn BM; Larhed M
Bioorg Med Chem; 2009 Aug; 17(16):5933-49. PubMed ID: 19635672
[TBL] [Abstract][Full Text] [Related]
37. Dietary flavonoids fisetin and myricetin: dual inhibitors of Plasmodium falciparum falcipain-2 and plasmepsin II.
Jin H; Xu Z; Cui K; Zhang T; Lu W; Huang J
Fitoterapia; 2014 Apr; 94():55-61. PubMed ID: 24468190
[TBL] [Abstract][Full Text] [Related]
38. Characterisation of Plasmodium falciparum aspartic protease inhibition by piperidine derivatives.
Saify ZS; Nisa M; Azhar KF; Azim MK; Rasheed H; Mushtaq N; Arain MA; Haider S; Khanum M; Ahmed W
Nat Prod Res; 2011 Dec; 25(20):1965-8. PubMed ID: 22050275
[TBL] [Abstract][Full Text] [Related]
39. Hydroxyethylamine Based Phthalimides as New Class of Plasmepsin Hits: Design, Synthesis and Antimalarial Evaluation.
Singh AK; Rathore S; Tang Y; Goldfarb NE; Dunn BM; Rajendran V; Ghosh PC; Singh N; Latha N; Singh BK; Rawat M; Rathi B
PLoS One; 2015; 10(10):e0139347. PubMed ID: 26502278
[TBL] [Abstract][Full Text] [Related]
40. Antimalarial and insecticidal activities of newly synthesized derivatives of Benzimidazole.
Kamil A; Akhter S; Ahmed M; Rizwani GH; Hassan S; Naeem S; Jahan S; Khursheed R; Zahid H
Pak J Pharm Sci; 2015 Nov; 28(6):2179-84. PubMed ID: 26639510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
